Literature DB >> 28412889

Diabetes Prevalence Among Racial-Ethnic Minority Group Members With Severe Mental Illness Taking Antipsychotics: Double Jeopardy?

Christina Mangurian1, Walker Keenan1, John W Newcomer1, Eric Vittinghoff1, Jennifer M Creasman1, Dean Schillinger1.   

Abstract

OBJECTIVE: This study assessed differences in diabetes prevalence based on race-ethnicity among people with severe mental illnesses.
METHODS: This retrospective cohort study examined diabetes prevalence in 2009 among California Medicaid enrollees with severe mental illness who were screened for diabetes (N=19,364). Poisson regression assessed differences in diabetes prevalence by race-ethnicity. The sample was standardized to the U.S.
RESULTS: The overall prevalence of diabetes was 32.0%. The adjusted prevalence for all minority groups with severe mental illness, except for Asians, was significantly higher than for whites (1.21-1.28 adjusted prevalence ratios). With inverse probability weighting to reduce selection bias captured by measured factors, estimated prevalence of diabetes among screened participants was 27.3%.
CONCLUSIONS: The prevalence of diabetes in minority groups with severe mental illness was significantly higher than among whites with severe mental illness. Mental health administrators should implement universal diabetes screening with specific outreach efforts targeting minority populations with severe mental illness.

Entities:  

Keywords:  Antipsychotics, Drug effects/cardiovascular, Ethnic groups, Research/service delivery, Diabetes; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28412889     DOI: 10.1176/appi.ps.201600356

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  6 in total

1.  Medical comorbid diagnoses among adult psychiatric inpatients.

Authors:  Matthew L Goldman; Christina Mangurian; Tom Corbeil; Melanie M Wall; Fei Tang; Morgan Haselden; Susan M Essock; Eric Frimpong; Franco Mascayano; Marleen Radigan; Matthew Schneider; Rui Wang; Lisa B Dixon; Mark Olfson; Thomas E Smith
Journal:  Gen Hosp Psychiatry       Date:  2020-06-23       Impact factor: 3.238

2.  Participant Experiences With a Peer-Led Healthy Lifestyle Intervention for People With Serious Mental Illness.

Authors:  Ana Stefancic; Lauren Bochicchio; Daniela Tuda; Kristen Gurdak; Leopoldo J Cabassa
Journal:  Psychiatr Serv       Date:  2021-03-04       Impact factor: 3.084

3.  Main Outcomes of a Peer-Led Healthy Lifestyle Intervention for People With Serious Mental Illness in Supportive Housing.

Authors:  Leopoldo J Cabassa; Ana Stefancic; Roberto Lewis-Fernández; José Luchsinger; Lara Carson Weinstein; Shenyang Guo; Lawrence Palinkas; Lauren Bochicchio; Xiaoyan Wang; Kathleen O'Hara; Michael Blady; Christine Simiriglia; Monica Medina McCurdy
Journal:  Psychiatr Serv       Date:  2020-12-18       Impact factor: 3.084

Review 4.  Cardiometabolic effects of psychotropic medications.

Authors:  Oluchi Abosi; Sneha Lopes; Samantha Schmitz; Jess G Fiedorowicz
Journal:  Horm Mol Biol Clin Investig       Date:  2018-01-10

5.  The magnitude of undiagnosed diabetes and Hypertension among adult psychiatric patients receiving antipsychotic treatment.

Authors:  Agete Tadewos Hirigo; Tesfaye Teshome
Journal:  Diabetol Metab Syndr       Date:  2020-09-07       Impact factor: 3.320

6.  Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China.

Authors:  Feiyun Ouyang; Jun He; Xunjie Cheng; Wei Zhou; Shuiyuan Xiao; Junqun Fang
Journal:  Front Psychiatry       Date:  2022-02-24       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.